Home / Market News / $INSP
benzinga Corporate Catalyst Impact 65/100 ● neutral

Inspire Medical Systems Receives American Medical Association CPT Editorial Panel Approval To Establish New Set Of Current Procedural Terminology Codes

Oct 1, 2026, 8:06 PM UTC · Primary ticker $INSP

Inspire Medical Systems announced that the AMA CPT Editorial Panel approved new Category I CPT codes for its Inspire V system, effective January 1, 2028. This development is positive for Inspire as it provides standardized billing and reimbursement for their technology, potentially increasing adoption and market access in the long term.

Inspire Medical Systems received approval from the AMA CPT Editorial Panel for new Category I CPT codes specifically for their Inspire V system. This is a significant long-term positive development because CPT codes are essential for standardized billing and reimbursement by insurance providers. While the codes don't take effect until January 1, 2028, this approval provides clarity and certainty for future reimbursement, which can accelerate adoption of the Inspire V system by healthcare providers and improve patient access. For traders, this creates a long-term opportunity for INSP as it de-risks a key aspect of commercialization and could lead to increased revenue growth post-2028. The short-term impact is likely moderate as the effective date is still several years away.

$INSP positive New CPT codes for its product
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.